The addition of a high concentration of exogenous ADO did not lead to a significant reduction in cytolysis against A549 cancer cells by cytokine-stimulated NK cells when primed with either IL-2 or a combination of IL-12 and IL-15 (Figures 5C,D). This evidence concerns the gene IL15 and cancer.